Clinical Trial

Resorbable Magnesium Scaffolds Registry

Recruiting
View on ClinicalTrials.gov →
Summary
The registry follows the ESC/EACTS guideline and further investigates the clinical performance and short-term safety of RMS (Resorbable Magnesium Scaffolds) in a real world setting within the scope of its intended use without further (medical related) exclusion criteria according to their respective instructions for use (IFU).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2020-12-17; most recent amendment 2025-11-18.
Trial Details
NCT Number NCT04679740
Lead Sponsor Biotronik AG
Conditions Coronary Artery Disease
Enrollment 1,106 participants
Start Date 2020-11-18
Primary Completion 2030-05 (estimated)
Study Completion 2030-05 (estimated)
Updated on ClinicalTrials.gov 2025-11-21